258 related articles for article (PubMed ID: 11752031)
21. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Yoshikawa N; Ito H; Sakai T; Takekoshi Y; Honda M; Awazu M; Ito K; Iitaka K; Koitabashi Y; Yamaoka K; Nakagawa K; Nakamura H; Matsuyama S; Seino Y; Takeda N; Hattori S; Ninomiya M
J Am Soc Nephrol; 1999 Jan; 10(1):101-9. PubMed ID: 9890315
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Yoshikawa N; Nakanishi K; Ishikura K; Hataya H; Iijima K; Honda M;
Pediatr Nephrol; 2008 May; 23(5):757-63. PubMed ID: 18224343
[TBL] [Abstract][Full Text] [Related]
23. Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center.
Koike M; Takei T; Uchida K; Honda K; Moriyama T; Horita S; Ogawa T; Yoshida T; Tsuchiya K; Nitta K
Clin Exp Nephrol; 2008 Aug; 12(4):250-255. PubMed ID: 18286351
[TBL] [Abstract][Full Text] [Related]
24. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
25. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
[TBL] [Abstract][Full Text] [Related]
27. The effects of cytotoxic therapy in progressive IgA nephropathy.
Shin JH; Lee JE; Park JH; Lim S; Jang HR; Kwon GY; Huh W; Jung SH; Kim YG; Oh HY; Kim DJ
Ann Med; 2016; 48(3):171-81. PubMed ID: 27031662
[TBL] [Abstract][Full Text] [Related]
28. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
29. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
Min L; Wang Q; Cao L; Zhou W; Yuan J; Zhang M; Che X; Mou S; Fang W; Gu L; Zhu M; Wang L; Yu Z; Qian J; Ni Z
Oncotarget; 2017 Jul; 8(29):48375-48384. PubMed ID: 28415636
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
[TBL] [Abstract][Full Text] [Related]
31. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
Choi S; Lee D; Jeong KH; Moon JY; Lee SH; Lee TW; Ihm CG
Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
[TBL] [Abstract][Full Text] [Related]
32. Effect of corticosteroids on renal function in progressive IgA nephropathy--long-term follow-up study.
Kobayashi Y; Hiki Y; Fujii K; Kurokawa A; Kamiyama M; Tateno S
Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1135-42. PubMed ID: 3216556
[No Abstract] [Full Text] [Related]
33. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.
Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Kitamura K
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1301-7. PubMed ID: 18508946
[TBL] [Abstract][Full Text] [Related]
34. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
Shoji T; Nakanishi I; Suzuki A; Hayashi T; Togawa M; Okada N; Imai E; Hori M; Tsubakihara Y
Am J Kidney Dis; 2000 Feb; 35(2):194-201. PubMed ID: 10676716
[TBL] [Abstract][Full Text] [Related]
35. [Management of IgA nephropathy].
Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
[TBL] [Abstract][Full Text] [Related]
36. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.
Donadio JV; Grande JP; Bergstralh EJ; Dart RA; Larson TS; Spencer DC
J Am Soc Nephrol; 1999 Aug; 10(8):1772-7. PubMed ID: 10446945
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Stangou M; Papagianni A; Bantis C; Moisiadis D; Kasimatis S; Spartalis M; Pantzaki A; Efstratiadis G; Memmos D
Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolic acid therapy after cyclophosphamide pulses in progressive IgA nephropathy.
Rasche FM; Keller F; von Müller L; Sailer LK; Karges W; Czock D
J Nephrol; 2006; 19(4):465-72. PubMed ID: 17048204
[TBL] [Abstract][Full Text] [Related]
40. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
